COF
63
-4
EMN
50
-2
CI
52
-7
DG
12
2
SWK
56
-6
EMC
53
-3
CAH
60
2
GIS
29
3
XOM
51
3
R
77
2
PLD
56
8
EXPE
96
-3
PG
50
2
RSG
77
4
AMG
43
3
DOV
73
4
GILD
56
-4
DIS
62
2
AON
60
2
PDCO
30
-6
COF
63
-4
EMN
50
-2
CI
52
-7
DG
12
2
SWK
56
-6
EMC
53
-3
CAH
60
2
GIS
29
3
XOM
51
3
R
77
2
PLD
56
8
EXPE
96
-3
PG
50
2
RSG
77
4
AMG
43
3
DOV
73
4
GILD
56
-4
DIS
62
2
AON
60
2
PDCO
30
-6
Financhill
Back

Catheter Precision Vs. Perspective Therapeutics Industry Stock Comparison

Buy
60

VTAK
Catheter Precision

Last Price:
0.51
Seasonality Move:
-1.88%
Sell
30

CATX
Perspective Therapeutics

Last Price:
8.92
Seasonality Move:
28.97%
Buy
60
Catheter Precision (VTAK) is a Buy

Is Catheter Precision a Buy, Sell or Hold?

  • The current Catheter Precision [VTAK] share price is $0.48. The Score for VTAK is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • VTAK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $9.93. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VTAK Stock Price Chart

What is Catheter Precision's stock price today?

  • The Catheter Precision share price today is $0.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VTAK is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $9.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

VTAK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 44.53 Sell
Chaikin Money Flow: -687544 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.37 - 0.73) Sell
Bollinger Bands (100): (0.07 - 3.03) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 28.07 Sell
Chaikin Money Flow: -952055 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.27 - 12.77) Sell
Bollinger Bands (100): (11.25 - 14.33) Sell

VTAK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.48 Buy
20-day SMA: 0.59 Sell
50-day SMA: 0.48 Sell
200-day SMA: 3.32 Sell
8-day EMA: 0.48 Sell
20-day EMA: 0.52 Sell
50-day EMA: 0.77 Sell
200-day EMA: 5.27 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.45 Sell
20-day SMA: 11.83 Sell
50-day SMA: 12.88 Sell
200-day SMA: 12.8 Sell
8-day EMA: 11.13 Sell
20-day EMA: 11.74 Sell
50-day EMA: 12.46 Sell
200-day EMA: 11.73 Sell

Catheter Precision Earnings Growth & VTAK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.70 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $4.90 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.80 per share, and a decrease next year of $0.22 per share.

Catheter Precision Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):